Injection Therapy for Erectile Dysfunction

Abstract
In this issue of the Journal, Linet and Ogrinc report that intracavernous-injection therapy with alprostadil (a synthetic prostaglandin E1) can produce good results in men with erectile dysfunction (impotence).1 It should be emphasized that the proper treatment of such men requires individualized evaluation and depends on the cause of their erectile dysfunction. The first step in management of erectile dysfunction is a comprehensive investigation that begins with a thorough medical history and physical examination. The causes are diverse and may be hormonal, psychological, vasculogenic, or neurogenic. Medications, especially antihypertensive and psychotropic drugs, can also cause impotence. Commonly, serum . . .